![Studijní programy](https://cdn.muni.cz/media/3757910/studijni-programy-student-jde-chodbou-masarykova-univerzita.jpg?mode=crop¢er=0.5,0.5&rnd=133754493890000000&heightratio=0.5&width=278)
Zde se nacházíte:
Informace o publikaci
Abstract 13625: Laboratory Markers of Effective Endogenous Fibrinolysis in Intermediate-High-Risk Pulmonary Embolism
Autoři | |
---|---|
Rok publikování | 2023 |
Druh | Konferenční abstrakty |
Citace | |
Popis | Introduction: Unselected therapy with fibrinolysis in intermediate risk-pulmonary embolism (iPE) is associated with an unacceptable risk of bleeding. Early identification of iPE patients on anticoagulant therapy with ineffective endogenous fibrinolysis (eFL) could optimize treatment-strategy. Aims: The study aims to determine markers of (in)effective eFL in intermediate-risk PE initially on anticoagulant therapy with UFH. |